Unichem Laboratories Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Pabitra Kumar Bhattacharyya
Chief executive officer
₹30.7m
Total compensation
| CEO salary percentage | 100.00% |
| CEO tenure | 2.3yrs |
| CEO ownership | n/a |
| Management average tenure | 6.8yrs |
| Board average tenure | 2.3yrs |
Recent management updates
Recent updates
Here's Why Unichem Laboratories (NSE:UNICHEMLAB) Can Manage Its Debt Responsibly
Aug 06
Unichem Laboratories' (NSE:UNICHEMLAB) Promising Earnings May Rest On Soft Foundations
Jul 12Potential Upside For Unichem Laboratories Limited (NSE:UNICHEMLAB) Not Without Risk
Jun 19We Think Unichem Laboratories (NSE:UNICHEMLAB) Can Stay On Top Of Its Debt
Feb 28Revenues Tell The Story For Unichem Laboratories Limited (NSE:UNICHEMLAB) As Its Stock Soars 26%
Nov 02It's A Story Of Risk Vs Reward With Unichem Laboratories Limited (NSE:UNICHEMLAB)
Sep 13Optimistic Investors Push Unichem Laboratories Limited (NSE:UNICHEMLAB) Shares Up 26% But Growth Is Lacking
Feb 06Is Unichem Laboratories (NSE:UNICHEMLAB) Using Debt Sensibly?
Feb 01Does Unichem Laboratories (NSE:UNICHEMLAB) Have A Healthy Balance Sheet?
Sep 06Unichem Laboratories (NSE:UNICHEMLAB) Is Due To Pay A Dividend Of ₹4.00
Jul 30There's Reason For Concern Over Unichem Laboratories Limited's (NSE:UNICHEMLAB) Massive 28% Price Jump
Jul 23Unichem Laboratories (NSE:UNICHEMLAB) Will Pay A Dividend Of ₹4.00
Jul 15Unichem Laboratories (NSE:UNICHEMLAB) Will Pay A Dividend Of ₹4.00
Jul 01Unichem Laboratories (NSE:UNICHEMLAB) Is Making Moderate Use Of Debt
Nov 27Investors Shouldn't Be Too Comfortable With Unichem Laboratories' (NSE:UNICHEMLAB) Robust Earnings
Jun 05Should Unichem Laboratories Limited (NSE:UNICHEMLAB) Be Part Of Your Income Portfolio?
Mar 02Unichem Laboratories Limited's (NSE:UNICHEMLAB) Stock's Been Going Strong: Could Weak Financials Mean The Market Will Correct Its Share Price?
Feb 09Should You Take Comfort From Insider Transactions At Unichem Laboratories Limited (NSE:UNICHEMLAB)?
Jan 19Do Institutions Own Unichem Laboratories Limited (NSE:UNICHEMLAB) Shares?
Dec 29Is Unichem Laboratories (NSE:UNICHEMLAB) Weighed On By Its Debt Load?
Dec 10Key Things To Understand About Unichem Laboratories' (NSE:UNICHEMLAB) CEO Pay Cheque
Nov 23
Did Unichem Laboratories' (NSE:UNICHEMLAB) Share Price Deserve to Gain 41%?
Nov 02Should You Buy Unichem Laboratories Limited (NSE:UNICHEMLAB) For Its 1.5% Dividend?
Oct 13How Much Are Unichem Laboratories Limited (NSE:UNICHEMLAB) Insiders Spending On Buying Shares?
Sep 16Is Unichem Laboratories (NSE:UNICHEMLAB) Using Too Much Debt?
Aug 26Is Unichem Laboratories Limited's (NSE:UNICHEMLAB) Shareholder Ownership Skewed Towards Insiders?
Aug 05Would Shareholders Who Purchased Unichem Laboratories'(NSE:UNICHEMLAB) Stock Three Years Be Happy With The Share price Today?
Jul 14Zooming in on NSE:UNICHEMLAB's 2.4% Dividend Yield
Jun 18CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2025 | n/a | n/a | ₹885m |
| Jun 30 2025 | n/a | n/a | ₹1b |
| Mar 31 2025 | ₹31m | ₹31m | ₹1b |
| Dec 31 2024 | n/a | n/a | -₹289m |
| Sep 30 2024 | n/a | n/a | -₹56m |
| Jun 30 2024 | n/a | n/a | -₹606m |
| Mar 31 2024 | ₹29m | ₹19m | -₹938m |
Compensation vs Market: Pabitra Kumar's total compensation ($USD343.90K) is about average for companies of similar size in the Indian market ($USD292.86K).
Compensation vs Earnings: Pabitra Kumar's compensation has been consistent with company performance over the past year.
CEO
Pabitra Kumar Bhattacharyya (56 yo)
Mr. Pabitra Kumar Kalipada Bhattacharyya had been Managing Director of Krebs Biochemicals & Industries Limited since August 1, 2021 until August 9, 2023 and had been its Additional Director since July 30,...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Director | 2.3yrs | ₹30.70m | no data | |
| Chief Financial Officer | 1.3yrs | ₹5.60m | no data | |
| Head of Legal | 6.3yrs | ₹10.70m | no data | |
| Chief Scientific & Compliance Officer | no data | no data | no data | |
| Vice President of Human Resources & ER | 17.4yrs | ₹7.48m | no data | |
| Head of Projects & Investments | no data | ₹2.10m | no data | |
| Chief Quality & Compliance Officer | no data | no data | no data | |
| Chief Manufacturing Officer of Formulations | less than a year | no data | no data | |
| Chief Executive of Domestic Pharma | 13.3yrs | ₹13.62m | no data | |
| President & CEO of Unichem Pharmaceuticals (USA) | 7.4yrs | no data | no data | |
| Vice President of Chemical of Research and Development | no data | ₹593.35k | no data | |
| Vice President of Commercial | 25yrs | ₹6.14m | no data |
Experienced Management: UNICHEMLAB's management team is seasoned and experienced (6.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Director | 2.3yrs | ₹30.70m | no data | |
| Chairman | 51.4yrs | ₹600.00k | 16.21% ₹ 5.4b | |
| Independent Director | 1.8yrs | ₹1.70m | 0.0014% ₹ 469.4k | |
| Non-Executive Non-Independent Director | 2.3yrs | ₹900.00k | no data | |
| Independent Director | 2.7yrs | ₹1.40m | no data | |
| Independent Director | 1.8yrs | ₹1.70m | no data |
Experienced Board: UNICHEMLAB's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/27 11:37 |
| End of Day Share Price | 2025/11/27 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Unichem Laboratories Limited is covered by 9 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Anand Rathi Shares and Stock Brokers Limited |
| Sriraam Rathi | Anand Rathi Shares and Stock Brokers Limited |
| Rohit Bhat | Batlivala & Karani Securities India Pvt. Ltd. |